Dr. Margaret McEntegart joins Columbia Interventional Cardiovascular Care to Lead Chronic Total Occlusion and Complex PCI Program

The Seymour, Paul, and Gloria Milstein Division of Cardiology at Columbia University Irving Medical Center/NewYork-Presbyterian is pleased to welcome Margaret B. McEntegart, MD, PhD, as a new faculty member of Columbia Interventional Cardiovascular Care. Dr. McEntegart will lead the Chronic Total Occlusion (CTO) and Complex Percutaneous Coronary Intervention (PCI) Program.

Dr. McEntegart will oversee Columbia’s complex PCI service, one of the leading programs for complex coronary care in New York City. In her role as director, she will provide training and support for junior faculty, supervision and mentorship for interventional cardiology fellows, and promote education for cardiodiologists and health professionals.

“I see my role as being a strong presence on the floor, firsthand through my own procedural work but also as support for the development of the younger faculty,” says Dr. McEntegart.

An internationally renowned interventional cardiologist and researcher, she served as a consultant interventional cardiologist at Golden Jubilee National Hospital—one of the largest PCI centers in the UK, with over 3,000 PCIs per year. While there, she established and led the CTO and Complex PCI Program. She also led their MitraClip service and expanded her role to support their transcatheter aortic valve replacement (TAVR) service.

Dr. McEntegart has delivered physician training in CTO and complex higher-risk (and indicated) patients (CHIP) PCI at centers in the U.S., UK, and Europe. She is an experienced live case operator and has served as faculty for large continuing medical education meetings, including TCT, CTO NYC, EuroPCR, Optimal CTO, EuroCTO, CRT, MLCTO and BCIS. 

Prior to joining Columbia, she held the position of associate professor of cardiology at the University of Glasgow, where she also earned her medical degree and PhD. She completed a National Research Scotland Fellowship, followed by a Harvard Global Clinical Research Scholarship. She was also named lead for the university’s interventional cardiology research.

Dr. McEntegart has been principal investigator for a number of local, national, and international clinical trials and co-supervised the university’s interventional cardiology PhD research fellows with Professor Colin Berry. She established the Glasgow Coronary Core Lab, providing analyses for research that included the UK multicenter T-TIME trial and the BCIS-REVIVED study.

Dr. McEntegart has a longstanding interest in supporting and expanding the ranks of women in interventional cardiology. “Less than 5% of interventional cardiologists in the UK are women,” she says. “And over the years, I’ve worked hard to try to change that. That's one of the things that my role at Columbia can help with: providing a bigger platform to try and influence that. I'll be able to encourage more trainees and more young women to take up interventional cardiology as a career.” She plans to serve as a mentor for female faculty in the division and actively further Columbia’s goal of greater equity and diversity. 

Her appointment also marks a return to NYP/Columbia, where she completed an interventional cardiology fellowship from 2010 to 2011. “I really enjoyed my time at Columbia, and I’m excited to return,” says Dr. McEntegart. “It’s going to be an interesting challenge, and I'm looking forward to it.”